Trial intelligence / Profile preview

Phase II study of liquid versus lyophilized live attenuated human rotavirus vaccine in healthy infants

2005-000449-12Phase 2Completed

Sponsor
GSK
Start
Jun 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea (3 arms), sponsored by GSK. Primary endpoint: Proportion of subjects with vaccine take on combined doses. Started Jun 2005; status: completed.

02

Drugs

human rotavirus RIX4414 strain vaccine
03

Conditions

rotaviral diarrhea

Beyond the preview

Go deeper on 2005-000449-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000449-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call